Surrogate marker in clinical studies with anti-angiogenic drugs.
Zirrgiebel
U
U
ProQinase and Tumor Biology Cente, Albert Ludwigs University, Freiburg, Germany.
Drevs
J
J
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis*; D017321:Clinical Trials, Phase I as Topic; D023381:Endpoint Determination; D006801:Humans; D008279:Magnetic Resonance Imaging; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy
D020533:Angiogenesis Inhibitors; D015415:Biomarkers